摘要
目的建立高效液相色谱-荧光测定法测定K562/DOX(doxorubicin-resistant K562 cells,耐多柔比星K562细胞)细胞核多柔比星浓度。方法分离K562/DOX细胞核,多柔比星浓度测定采用Diamond C18色谱柱,甲醇-水-醋酸(50∶50∶0.25)为流动相,流速1.0mL·min-1,柱温35℃,荧光检测,激发波长497nm,发射波长555nm,以盐酸柔红霉素为内标。结果细胞核中多柔比星浓度在5.0～5000.0μg·L-1内呈良好线性关系,r=0.9999。加样回收率为98.55%～100.84%(RSD1.77%～3.27%),日内和日间精密度均<15%,最低检测浓度为5.0μg·L-1。结论该方法简单、方便,检测限低,精确度和回收率良好,可用于多药耐药肿瘤细胞内多柔比星浓度的胞内动力学研究。
Abstract
OBJECTIVE To develop a method using HPLC with fluorescence detector for determining the Doxorubicin concentrations in K562/DOX cell nuclei.METHODS Nuclei were isolated by modifying a method that employed isotonic conditions and detergent lysis. The mobile phase consisted of methanol-water-acetic acid (50∶50∶0.25). The flow rate of the mobile phase was set at 1.0 mL·min-1, and the eluent was monitored at an excitation wavelength of 497 nm and an emission wavelength of 555 nm. Calibration curves were computed using the area ratio of doxorubicin to daunorubicin (the internal standard).RESULTS The linear calibration curve was observed in the concentration range of 5.0-1 000 μg·L-1. The lower limit of quantification was 5.0 μg·L-1. The spotting recoveries were 98.55%-100.84%. The inter-and intra-day precision (RSD) was below 15%. CONCLUSION The method was proved to be convenient,sensitive and rapid,and suitable for the determination of doxorubicin in nuclei.
关键词
高效液相色谱法 /
多柔比星 /
细胞核 /
K562/DOX细胞
{{custom_keyword}} /
Key words
HPLC /
doxorubicin /
nuclei /
K562/DOX cell
{{custom_keyword}} /
许东航;高建青;梁文权;赵永星 .
高效液相色谱法测定细胞核内多柔比星浓度[J]. 中国药学杂志, 2008, 43(16): 1264-1267
XU Dong-hng;GO Jin-qing;LING Wen-qun;ZHO Yong-xing;.
Determination of Doxorubicin Concentrations in MDR Cancer Cell Nuclei by HPLC [J]. Chinese Pharmaceutical Journal, 2008, 43(16): 1264-1267
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] ROBERT J，JARRY C. Multidrug resistance reversal agents[J] . J Med Chem，2003，46(23)：4805-4817.
[2] KRISHNA R，MAYER L D. Multidrug resistance (MDR) in cancer. Mechanisms，reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs[J] . Eur J Pharm Sci，2000，11(4)：265-283.
[3] XIONG X B，HUANG Y，LU W L，et al. Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic[J] .J Controlled Release，2005，107(2)：262-275.
[4] WONG H L，RAUTH A M，BENDAYAN R，et al. A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells[J] .Pharm Res，2006，23(7)：1574-1585.
[5] XIONG G，CHEN Y，ARRIAGA E A. Measuring the doxorubicin content of single nuclei by micellar electrokinetic capillary chromatography with laser-induced fluorescence detection[J] .Anal Chem（分析化学），2005，77(11)：3488-3493.
[6] ALAKHOV V Y，MOSKALEVA E Y，BATRAKOVA E V，et al. Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer[J] . Bioconjug Chem，1996，7(2)：209-216.
[7] ALAKHOV V，KLINSKI E，LI S，et al. Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials[J] .Colloids and Surfaces B： Biointerfaces，1999，16(1-4)：113-134.
[8] LAHIRI D K，GE Y. Electrophoretic mobility shift assay for the detection of specific DNA-protein complex in nuclear extracts from the cultured cells and frozen autopsy human brain tissue[J] . Brain Res Brain Res Protoc，2000，5(3)：257-265.
[9] WANG L，YU M L，YANG J S，et al. The effects of hydrogenated and non-hydrogenated egg phosphatidylcholine on the pharmacokinetic parameters of doxorubicin liposomes[J] .Chin Pharm J(中国药学杂志)，2001，36(8)：539-542.
[10] REN Y，WEI D. Quantification intracellular levels of oligodeoxynucleotide-doxorubicin conjugate in human carcinoma cells in situ[J] .J Pharm Biomed Anal，2004，36(2)：387-391.
[11] ZHANG H Y，SHEN P，LUAN L J，et al. An approach to determination of the intracellular and extracellular concentrations of doxorubicin for MDR cancer cells[J] .Acta Chim Sin(化学学报)，2004，62(12)：1162-1165.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
国家自然科学基金资助项目(30572270);浙江省自然科学基金项目(Y207259)
{{custom_fund}}
